ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,512, issued on Dec. 30, was assigned to Ramot at Tel-Aviv University Ltd. (Tel-Aviv, Israel).
"Semaphorin 3A antibodies and uses thereof" was invented by Itai Benhar (Tel-Aviv, Israel), Arieh S. Solomon (Tel-Aviv, Israel), Ari Barzilai (Tel-Aviv, Israel), Limor Nahary (Tel-Aviv, Israel), Anat Nitzan (Tel-Aviv, Israel), Mary Safrin (Tel-Aviv, Israel), Marina Bruzel (Tel-Aviv, Israel) and Ronit Galron (Tel-Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies comprising an antigen recognition region which binds a semaphorin 3A (Sema3A) are disclosed. Uses thereof are also disclosed."
The patent was filed on June 25, 2020, under Appli...